Clinical use of differential nuclear medicine modalities in patients with ATTR amyloidosis

Amyloid

Volumn 19, Issue 4, 2012, Pages 208-211

  Noordzij, Walter ^a   Glaudemans, Andor W J M ^a   Slart, Riemer H J A ^a   Dierckx, Rudi A ^a   Hazenberg, Bouke P C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Amyloidosis; Bone; Cardiac; Nuclear medicine; Sympathetic

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; OXIDRONATE TECHNETIUM TC 99M; SERUM AMYLOID P;

AGED; AMYLOIDOSIS; ANKLE EDEMA; ARTICLE; BONE SCINTISCANNING; DENERVATION; DIASTOLIC HEART FAILURE; DYSPNEA; FEMALE; HEART AMYLOIDOSIS; HUMAN; IMAGE QUALITY; LUNG ARTERY PRESSURE; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION; WILD TYPE;

AGED; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; MALE; NUCLEAR MEDICINE; RADIOPHARMACEUTICALS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84868371211     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2012.717993     Document Type: Article

References (13)

1. van Gameren II, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum 2006;54:2015-2021. (Pubitemid 43877954)
2. Ando Y, Ueda M. Diagnosis and therapeutic approaches to transthyretin amyloidosis. Curr Med Chem 2012;19:2312-2323.
3. Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med 1990;323:508-513. (Pubitemid 20260051)
4. Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, Hawkins PN, Jager PL. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 2006;119:355.e15-355.e24.
5. Hawkins PN. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 2002;11:649-655. (Pubitemid 35440848)
6. Hazenberg BP, van Rijswijk MH, Lub-de Hooge MN, Vellenga E, Haagsma EB, Posthumus MD, Jager PL. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis. J Nucl Med 2007;48:865-872. (Pubitemid 46909912)
7. Glaudemans AW, Slart RH, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BP, Dierckx RA. Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging 2009;36:702-714.
8. Puille M, Altland K, Linke RP, Steen-Müller MK, Kiett R, Steiner D, Bauer R. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy. Eur J Nucl Med Mol Imaging 2002;29:376-379. (Pubitemid 34253251)
9. Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, Leone O et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005;46:1076-1084. (Pubitemid 41316518)
10. Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, Ferlini A et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging 2011;4:659-670.
11. Camacho V, Carrió I. Targeting neuronal dysfunction and receptor imaging. Curr Opin Biotechnol 2007;18:60-64. (Pubitemid 46227969)
12. Noordzij W, Glaudemans AW, van Rheenen RW, Hazenberg BP, Tio RA, Dierckx RA, Slart RH. (123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloi dosis. Eur J Nucl Med Mol Imaging (In Press).
13. Furukawa K, Ikeda S, Okamura N, Tashiro M, Tomita N, Furumoto S, Iwata R et al. Cardiac positron-emission tomography images with an amyloid-specific tracer in familial transthyretin-related systemic amyloidosis. Circulation 2012;125:556-557.